Product image of Irbesartán/Hidroclorotiazida Cinfa (Hydrochlorothiazide, Irbesartan) supplied by GNH India

Irbesartán/Hidroclorotiazida Cinfa

Active Ingredient:
Hydrochlorothiazide, Irbesartan
Origin:
EU

Irbesartán/Hidroclorotiazida Cinfa (Hydrochlorothiazide, Irbesartan)

Irbesartan/Hydrochlorothiazide, the active ingredient in Irbesartán/Hidroclorotiazida Cinfa, is an angiotensin II receptor blocker and thiazide diuretic presented as a tablet for oral use. It treats hypertension in adult patients.
GNH India supplies Irbesartán/Hidroclorotiazida Cinfa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Laboratorios Cinfa S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Irbesartan/Hydrochlorothiazide is used to manage high‑blood‑pressure conditions within the antihypertensive drug class.

  • Essential hypertension: lowers systolic and diastolic blood pressure to target levels.
  • Hypertension requiring diuretic therapy: adds diuretic effect to improve blood‑pressure control.
  • Hypertension with fluid retention: reduces plasma volume and vascular resistance for better control.

How It Works

  • Irbesartan selectively blocks AT1 receptors, preventing angiotensin II‑mediated vasoconstriction and aldosterone release. Hydrochlorothiazide inhibits NaCl reabsorption in the distal convoluted tubule, promoting natriuresis and diuresis, which together lower peripheral resistance and plasma volume, resulting in reduced arterial pressure.

Side Effects

Adverse reactions may occur with any antihypertensive combination therapy.

Common Side Effects

  • Dizziness or light‑headedness.
  • Headache.
  • Fatigue.
  • Increased urination.
  • Electrolyte disturbances (e.g., low potassium).
  • Mild gastrointestinal upset.

Serious or Rare Side Effects

  • Severe hypotension.
  • Acute kidney injury.
  • Hyperkalemia.
  • Angioedema.
  • Hepatic dysfunction.
  • Severe electrolyte imbalance (e.g., hyponatremia).

Precautions & Warnings

Before initiating therapy, consider the following safety measures.

  • Renal impairment: monitor kidney function and adjust therapy as needed.
  • Electrolyte balance: check serum potassium and sodium regularly.
  • Pregnancy: avoid use unless clearly needed; discuss risks with a healthcare professional.
  • Concomitant drugs: review all medications for potential interactions.
  • Elderly patients: start at lower doses and monitor closely for orthostatic effects.
  • Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Avoid Interactions

Irbesartan/Hydrochlorothiazide may interact with several drug classes.

Major Interactions (Avoid)

  • Potassium‑sparing diuretics or supplements: risk of hyperkalemia.
  • Lithium: increased lithium levels and toxicity.
  • NSAIDs: may reduce antihypertensive effect and impair renal function.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors or other ARBs: additive risk of renal dysfunction.
  • Antidiabetic agents: may require dose adjustment due to blood‑glucose changes.
  • Antihypertensive agents (beta‑blockers, calcium channel blockers): monitor for excessive blood‑pressure lowering.

Frequently Asked Questions

Irbesartán/Hidroclorotiazida is a fixed‑dose combination of irbesartan and hydrochlorothiazide indicated for the treatment of hypertension in adult patients, helping to lower elevated blood‑pressure readings and reduce cardiovascular risk.

Irbesartan blocks the angiotensin II type‑1 (AT1) receptors, preventing vasoconstriction and aldosterone release, which leads to relaxation of blood vessels and reduced blood‑pressure levels.

The specific dose is determined by the prescribing clinician based on the patient’s blood‑pressure profile, renal function, and concomitant therapies. Dosage adjustments are individualized and should follow the prescriber’s instructions.

Use during pregnancy is generally discouraged unless the potential benefit outweighs the risk, as safety data are limited. Breastfeeding mothers should consult their healthcare provider, as the drug may pass into milk.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with single‑agent therapies, the combination offers dual mechanisms—AT1‑receptor blockade and diuresis—providing more potent blood‑pressure reduction in patients who need both actions, often simplifying dosing regimens.

Store the tablets at room temperature, below 25 °C, in the original container, protected from moisture and direct sunlight to maintain product stability.

The medication is taken orally, usually once daily, with or without food, as directed by the prescribing healthcare professional.

Serious adverse events can include severe hypotension, acute kidney injury, hyperkalemia, angioedema and significant electrolyte disturbances; patients should be monitored for these conditions.

Patients with known hypersensitivity to irbesartan, hydrochlorothiazide, or any component of the formulation, as well as those with severe renal impairment, uncontrolled hyperkalemia, or a history of angioedema, should avoid this medication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.